A volunteer being vaccinated by a medic during the Bharat Biotech's 'Covaxin' human trial. (PTI)
HYDERABAD: Vaccine maker Bharat Biotech on Tuesday said it has inked an agreement with Brazil’s Precisa Medicamentos for distribution of India’s first indigenous Covid-19 vaccine Covaxin in the Brazilian market. The Covaxin doses will be manufactured in India and exported to Brazil where they will be distributed by Precisa.
According to Bharat Biotech, the two players have, agreed in principle, that the supplies of Covaxin will be prioritised for the public market through a direct procurement by the Brazilian government. The supplies to the private market will be made based on the market authorization from the Brazilian regulatory authority ANVISA.